- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06669689
The Impact of Anesthesia and Positioning on Cerebral Blood Flow and Pressure in Patients Undergoing Laparoscopic Surgery
The Impact of Anesthesia and Positioning on Cerebral Blood Flow and Pressure in Patients Undergoing Laparoscopic Surgery: an Observational Study
The aim of this observational study was to understand the effect of ReverseTrendelenburg position, Trendelenburg position on intracranial pressure and carotid blood flow in patients undergoing laparoscopic surgery. The main question it aims to answer is:
Does ReverseTrendelenburg position increase common carotid artery (CCA) flow, optic nerve sheath diameter (ONSD); does Trendelenburg position decrease CCA flow, ONSD.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study was approved by the Medical Ethics Committee of Inner Mongolia Baogang Hospital, on January 11, 2023 (2023-MER-26),follow the Declaration of Helsinki. All participants voluntarily agreed to participate and signed informed consent forms. Between February 2023 and December 2023, 76 patients, all classified as ASA I-II adults, were selected at Baogang Hospital, Inner Mongolia. Patients were excluded if they had an allergy to anesthetics used in this study or experienced adverse reactions to analgesics included in the study. Patients were deemed ineligible for clinical evaluation if they refused to sign the consent form or were uncooperative. We excluded patients with a body mass index (BMI) ≥30 kg m-2, uncontrolled hypertension, uncontrolled diabetes, cirrhosis or renal impairment, cardiopulmonary insufficiency, cerebrovascular disease, glaucoma, persistent eye infections, or a history of ophthalmic surgery.
Upon entering the operating room, patients were monitored for pulse oximetry, ECG, BIS, and non-invasive arterial blood pressure. Prior to surgery, patients were administered Penehyclidine Hydrochloride Injection (Lot H20051948, Chengdu List Pharmaceutical Co., Ltd., China) at a dose of 0.01 mg kg-1i.v.. Patients were induced with propofol (1.5-2 mg kg-1i.v.), rocuronium (1-2 mg kg-1i.v.), and fentanyl (1-2μg kg-1i.v.). Anesthesia was maintained with inhaled sevoflurane or desflurane, with inhalation concentrations adjusted according to BIS. Remifentanil (0.05-0.2μg kg-1 min-1i.v.) was continuously infused, with blood pressure and heart rate adjusted to ±20% of baseline values. After induction, patients were mechanically ventilated using the Pressure-Regulated Volume Control (PRVC) mode. Ventilator parameters were set as tidal volume 6-8 ml kg-1, PEEP 0 cmH2O, I ratio of 1:2, respiratory rate 16 breaths per minute (BPM), and FiO2 of 41%. In the Trendelenburg position, the operating table was tilted head down at an angle of 20-25°. In the Reverse Trendelenburg position, the operating table was tilted head up at an angle of 20-25°. Pneumoperitoneum was established with an intra-abdominal pressure of 10-15 mmHg.
Measurements were recorded at five time points: before anesthesia (T1), after intubation (T2), after position change (Trendelenburg or Reverse Trendelenburg position) (T3), after pneumoperitoneum (T4), and at the end of surgery (T5)( Fig 1 b). Parameters measured included mean arterial pressure (MAP; calculated as diastolic pressure + 1/3 pulse pressure), heart rate (HR), Bispectral Index (BIS), PIP, end-tidal carbon dioxide (ETCO2), tidal volume (TV), common carotid artery (CCA) flow, CCA beat volume, CCA diameter, and optic nerve sheath diameter (ONSD). CCA flow, CCA beat volume, CCA diameter, and ONSD were measured using ultrasound by a trained researcher. Ultrasound measurements were performed using the LOGIQ™ E20 device (GE Healthcare, Chicago, Illinois, USA) equipped with a linear 7.5 MHz ultrasound transducer (GE Healthcare, Chicago, Illinois, USA) and a 2.5 MHz ultrasound transducer (GE Healthcare, Chicago, Illinois, USA) to assess optic nerve sheath diameter and common carotid artery blood flow. For each time point, three measurements were taken, and the average value was recorded. Other data were recorded by the anesthesiologist or anesthesia nurse.
In the Postanesthetic Care Unit (PACU), the following parameters were monitored and recorded: length of stay, mean arterial pressure, heart rate, postoperative nausea and vomiting, pain, rescue antiemetics, rescue analgesics, and rescue sulfentanil dose.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Inner Mongolia
-
Baotou, Inner Mongolia, China, 014010
- Inner Mongolia Baogang Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- agreed to participate and signed informed consent forms
- classified as ASA I-II adults
Exclusion Criteria:
- allergy to anesthetics
- refused to sign the consent form or were uncooperative
- a body mass index (BMI) ≥30 kg m-2
- uncontrolled hypertension
- uncontrolled diabetes
- cirrhosis or renal impairment
- cardiopulmonary insufficiency
- persistent eye infections, or a history of ophthalmic surgery
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
the TREND group (Trendelenburg position)
In the Trendelenburg position, the operating table was tilted head down at an angle of 20-25°.
|
In the Trendelenburg position, the operating table was tilted head down at an angle of 20-25°.
In the Reverse Trendelenburg position, the operating table was tilted head up at an angle of 20-25°.
Other Names:
Pneumoperitoneum was established with an intra-abdominal pressure of 10-15 mmHg.
|
|
the Reverse Trendelenburg position
In the Reverse Trendelenburg position, the operating table was tilted head up at an angle of 20-25°
|
In the Trendelenburg position, the operating table was tilted head down at an angle of 20-25°.
In the Reverse Trendelenburg position, the operating table was tilted head up at an angle of 20-25°.
Other Names:
Pneumoperitoneum was established with an intra-abdominal pressure of 10-15 mmHg.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
common carotid artery (CCA) flow
Time Frame: From February 2023 to December 2023
|
If it was significantly lower than pre-anesthetic, it was considered that the position and pneumoperitoneum affected the cerebral blood supply.
|
From February 2023 to December 2023
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
optic nerve sheath diameter (ONSD)
Time Frame: From February 2023 to December 2023
|
If significantly higher than pre-anesthetic, it is thought that the position and pneumoperitoneum have increased intracranial pressure.
|
From February 2023 to December 2023
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xiangyu Wang, Undergraduate, Inner Mongolia Baogang Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2023-MER-26
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopic Surgery
-
Sefako Makgatho Health Sciences UniversityCompletedLaparoscopic Surgery | Laparoscopic Entry Technique
-
Indonesia UniversityCompletedLaparoscopic Surgery | Abdominal SurgeryIndonesia
-
Case Comprehensive Cancer CenterCompletedLaparoscopic Surgery | Vaginal SurgeryUnited States
-
Imperial College LondonCompletedLaparoscopic Surgery | Minimally Invasive SurgeryUnited Kingdom
-
National Institute of Cardiology, Laranjeiras,...Completed
-
Hospital Universitario La FeCompleted
-
Zagazig UniversityCompletedLaparoscopic SurgeryEgypt
-
University of MalayaCompleted
-
Alkermes, Inc.TerminatedLaparoscopic SurgeryUnited States
-
M.S.T. Medical Surgery Technology LTD.CompletedGeneral Laparoscopic Surgery Candidate | Bariatric Laparoscopic Surgery CandidateUnited States
Clinical Trials on operating position
-
Musgrave Park HospitalBelfast Health and Social Care Trust; Queen's University, Belfast; Belfast Arthroplasty...CompletedTotal Hip Replacement | Total Hip Arthroplasty | THA | THRUnited Kingdom
-
University Hospital, LilleCompletedHypovolemia | Somatic PainFrance
-
Milton S. Hershey Medical CenterRecruiting
-
Maternal and Child Health Hospital of FoshanRecruitingEmergency Cesarean SectionChina
-
Imperial College LondonTerminated
-
Beijing Tsinghua Chang Gung HospitalEnrolling by invitation
-
Sandwell & West Birmingham Hospitals NHS TrustCompletedFractures, Bone | Orthopedic Disorder | Neck of Femur FractureUnited Kingdom
-
Data Collection Analysis Business ManagementPAS Research ServicesUnknownDietary Allergy | Environmental AllergyUnited States
-
Chulalongkorn UniversityNot yet recruiting
-
Antalya Training and Research HospitalCompleted